SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Epigral - Quaterly Results

11 Nov 2025 Evaluate
The sales slipped to Rs. 5873.60 millions for the September 2025 quarter as against Rs. 6260.60 millions during the year-ago period.A big decline of -36.02% was reported for the quarter ended September 2025 to Rs. 515.20  millions from Rs. 805.30 millions of corresponding previous quarter.A decline of 1341.00 millions was observed in the OP in the quarter ended September 2025 from 1839.80 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 5873.60 6260.60 -6.18 11939.00 12772.60 -6.53 25501.30 19291.90 32.19
Other Income 17.40 55.50 -68.65 99.90 79.50 25.66 152.10 65.20 133.28
PBIDT 1341.00 1839.80 -27.11 3057.40 3627.80 -15.72 7259.30 4877.20 48.84
Interest 218.40 273.20 -20.06 452.10 415.70 8.76 532.70 734.90 -27.51
PBDT 1122.60 1566.60 -28.34 2605.30 3212.10 -18.89 6726.60 4142.30 62.39
Depreciation 423.10 322.50 31.19 838.50 657.00 27.63 1325.60 1235.60 7.28
PBT 699.50 1244.10 -43.77 1766.80 2555.10 -30.85 5401.00 2906.70 85.81
TAX 184.30 438.80 -58.00 -352.50 889.70 -139.62 1834.00 948.80 93.30
Deferred Tax 8.70 219.60 -96.04 -782.00 438.80 -278.21 852.30 421.70 102.11
PAT 515.20 805.30 -36.02 2119.30 1665.40 27.25 3567.00 1957.90 82.18
Equity 431.40 415.50 3.83 431.40 415.50 3.83 431.40 415.50 3.83
PBIDTM(%) 22.83 29.39 -22.31 25.61 28.40 -9.84 28.47 25.28 12.60

Epigral Share Price

1328.80 125.55 (10.43%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×